On Thursday, KBR, Inc. (NYSE:KBR)’s shares inclined 0.06% to $16.67.
KBR, Inc. (KBR) declared it has been awarded a prime contractor position for a multiple award indefinite-delivery/indefinite quantity (IDIQ) contract by the U.S. Air Force for base life support and logistics and construction services worldwide.
KBR is one of eight companies awarded a prime contractor position to compete for specific task orders on the $5B Air Force Contract Augmentation Program (AFCAP IV).
AFCAP IV, awarded by the 772nd Enterprise Sourcing Squadron, Air Force Installation Contracting Agency at Tyndall Air Force Base in Florida, will provide base life and operating support, logistics support, and construction services as needed to support the Air Force, Department of Defense, or any U.S. federal government entity performing contingency operations. Work will be performed at locations worldwide to be determined by individual needs. This work is predictable to be performed over seven years, with funding allocated to orders on an as-required basis in support of the AFCAP scope of services.
KBR, Inc. operates as an engineering, construction, and services company worldwide. The company operates through three segments: Technology & Consulting, Engineering & Construction, and Government Services. The Technology & Consulting segment offers various services and solutions, counting licensing, engineering and design, proprietary equipment, plant automation, catalysts, and related consulting services to hydrocarbons, chemicals, and fertilizer markets.
American Axle & Manufact. Holdings, Inc. (NYSE:AXL)’s shares dropped -2.01% to $19.54.
American Axle & Manufacturing, Inc. (AAM) declared that Tolga Oal has been designated President - AAM North America (Vice President – AAM Corporate). In this role, Mr. Oal will lead AAM’s regional business and manufacturing activities for North America.
Oal joins AAM from TRW Automotive, having served as Vice President of Global Electronics, a position he has held since 2012. Before his current assignment, Mr. Oal served in various manufacturing and administration positions of increasing responsibility within TRW for Global Electronics, counting director of Operations and as director of Finance. Preceding to joining TRW, Oal held various leadership positions in engineering, sales, purchasing, and finance at Siemens VDO Automotive/Continental.
Oal holds a Bachelor of Science degree in Chemical and Process Engineering from Bosporus University, Istanbul, Turkey, and a Masters in International Business and Finance from the University of Florida in Gainesville.
American Axle & Manufacturing Holdings, Inc., together with its auxiliaries, designs, engineers, validates, and manufactures driveline and drivetrain systems, and related components and chassis modules for the automotive industry in the United States, Canada, Mexico, South America, Asia, Europe, and internationally.
At the end of Thursday’s trade, Laboratory Corp. of America Holdings (NYSE:LH)‘s shares surged 1.58% to $110.18.
Laboratory Corporation of America® Holdings (LabCorp®) (LH) declared that Covance Drug Development will open a cGMP-compliant pharmacy at its clinical research unit in Madison, Wisconsin, allowing for on-site production of high-quality, customized pharmaceutical products for clinical trials. Covance, which opened its first cGMP pharmacy at its Dallas, Texas facility earlier this year, is the only CRO to implement cGMP standards for Phase I manufacturing of investigational drug products in a U.S. Phase I clinical research unit. The Madison cGMP pharmacy will be accessible for client audits startning in October.
Small-scale cGMP manufacturing meets the highest regulatory and safety standards and lowers the cost to manufacture pharmaceutical products for clinical trials. Covance’s innovative facilities offer certified clean rooms that support a full range of sterile manufacturing, counting aseptically prepared sterile parenteral investigative drugs and radiolabelled doses, in addition to non-sterile investigational drug products.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
Total System Services, Inc. (NYSE:TSS), ended its Thursday’s trading session with 0.86% gain, and closed at $45.82.
TSYS (TSS) will issue its third-quarter earnings report on October 27, 2015, at about 4:15 p.m. ET. A conference call to talk about these results, business trends and future projections will be held on October 27, 2015, at 5:00 p.m. ET. Shareholders and other interested persons may listen to this conference call via simultaneous internet broadcast at www.tsys.com by clicking on the link under “Webcasts” on the homepage. You must download Windows Media Player (free download accessible) before accessing the conference call or the replay. The conference call will be archived for 12 months and will be accessible starting 30 to 45 minutes after the call ends.
Total System Services, Inc. provides electronic payment processing services to banks and other financial institutions in the United States, Europe, Canada, Mexico, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
